Autopsy

Alexion Pharmaceuticals' Soliris NDA for PNH receives authorization in Japan Alexion Pharmaceuticals, Inc. PNH is an ultra-rare, life-threatening and debilitating bloodstream disorder defined by chronic crimson blood ...

'With the economic challenges we face today, the amount of pressure and competitiveness will continue steadily to escalate. It must be a responsibility of institutions to help their physicians take care of their well-...